Abstract
BIFAP includes information routinely collected by primary care physicians (PCPs) in their practices (real-world data). In 2018, the BIFAP database included anonymized and prospectively recorded data in the electronic medical records (EMR) of 7566 PCPs (6419 General Practitioners (GPs)/1147 pediatricians) up to the end of 2018.
BIFAP Team: Alicia Gonzalez, Carlos León, Luz León, Ana Llorente, Mar Martín.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbing-Karahagopian V, Huerta C, Souverein PC et al (2014) Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol 70(7):849–857. https://doi.org/10.1007/s00228-014-1676-z
Aguilar-Shea AL, Bonis J (2019) COPD from an everyday primary care point of view. J Fam Med Prim Care 8(8):2644–2650. https://doi.org/10.4103/jfmpc.jfmpc_477_19
Article 29 Data Protection Working Party (2014) 0829/14/EN WP216 Opinion 05/2014 on Anonymisation techniques adopted on 10 April 2014. http://ec.europa.eu/justice/article-29/documentation/opinion-recommendation/files/2014/wp216_en.pdf. Accessed 12 Dec 2019
Baladé Martínez L, Montero Corominas D, Macías Saint-Gerons D (2016) Utilization of hormone replacement therapy in Spain: trends in the period 2000–2014. Med Clin (Barc) 147(7):287–292. https://doi.org/10.1016/j.medcli.2016.05.023
Bernal-Delgado E, Garcia-Armesto S, Oliva J et al (2018) Spain: health system review. Health Syst Transit 20(2):1–179
BIFAP (2019) Base de Datos para la Investigación Farmacoepidemiológica en Atencion Primaria. http://www.bifap.org/. Accessed 12 Dec 2019
Bonis JS, Hoyos MCA, Llorente AG et al (2013) Prevalencia de uso de fármacos para el tratamiento de la enfermedad de Alzheimer y su evolución temporal: un estudio descriptivo con la base de datos de atención primaria BIFAP. Alzheimer Realidades e investigación en demencia 54:20–27. https://doi.org/10.5538/1137-1242.2013.54.20
Braeye T, Bauchau V, Sturkenboom M et al (2019) Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation—a contribution of the ADVANCE-project. PLoS ONE 14(9):e0222296. https://doi.org/10.1371/journal.pone.0222296
Brauer R, Douglas I, Garcia Rodriguez LA et al (2016a) Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe. Pharmacoepidemiol Drug Saf 25(s1):29–38. https://doi.org/10.1002/pds.3861
Brauer R, Ruigómez A, Downey G et al (2016b) Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiol Drug Saf 25(s1):11–20. https://doi.org/10.1002/pds.3831
Centers for Disease Control and Prevention (2015) ICD—ICD-9-CM—international classification of diseases, Ninth Revision, clinical modification. https://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed 12 Dec 2019
Chacón García A, Ruigómez A, García Rodríguez LA (2010) Incidence rate of community acquired pneumonia in a population cohort registered in BIFAP. Aten Primaria 42(11):543–549. https://doi.org/10.1016/j.aprim.2010.05.004
CORDIS. EU research results (2019) SAFEGUARD. https://cordis.europa.eu/project/id/282521/reporting. Accessed 12 Dec 2019
de Abajo FJ, Gil MJ, Bryant V et al (2013) Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol 69(3):691–701. https://doi.org/10.1007/s00228-012-1386-3
de Abajo FJ, Gil MJ, García Poza P et al (2014) Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study. Pharmacoepidemiol Drug Saf 23(11):1128–1138. https://doi.org/10.1002/pds.3617
de Abajo FJ, Gil MJ, Rodríguez A et al (2015) Allopurinol use and risk of non-fatal acute myocardial infarction. Heart 101(9):679–685. https://doi.org/10.1136/heartjnl-2014-306670
de Abajo FJ, Rodríguez-Martín S, Rodríguez-Miguel A et al (2017) Risk of ischemic stroke associated with calcium supplements with or without vitamin D: a nested case-control study. J Am Heart Assoc 6(5):e005795. https://doi.org/10.1161/JAHA.117.005795
de Groot MCH, Schuerch M, de Vries F et al (2014) Antiepileptic drug use in seven electronic health record databases in Europe: a methodologic comparison. Epilepsia 55(5):666–673. https://doi.org/10.1111/epi.12557
de Hoyos-Alonso MC, Bonis J, Tapias-Merino E et al (2016) Estimated prevalence of dementia based on analysis of drug databases in the Region of Madrid (Spain). Neurología (Barcelona, Spain) 31(1):1–8. https://doi.org/10.1016/j.nrl.2014.08.008
Emborg H-D, Kahlert J, Braeye T et al (2019) ADVANCE system testing: can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example. Vaccine. https://doi.org/10.1016/j.vaccine.2019.07.039
Erviti J, Alonso A, Gorricho J et al (2013a) Oral bisphosphonates may not decrease hip fracture risk in elderly Spanish women: a nested case-control study. BMJ Open 3(2):e002084. https://doi.org/10.1136/bmjopen-2012-002084
Erviti J, Alonso A, Oliva B et al (2013b) Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study. BMJ Open 3(1):e002091. https://doi.org/10.1136/bmjopen-2012-002091
European Parliament (2016) Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation). https://eur-lex.europa.eu/eli/reg/2016/679/oj. Accessed 12 Dec 2019
García-Poza P, de Abajo FJ, Gil MJ et al (2015) Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study. J Thromb Haemost 13(5):708–718. https://doi.org/10.1111/jth.12855
Gil M, González-González R, Vázquez-Calvo A et al (2019a) Clinical infections by Herpesviruses in patients treated with Valproic acid: a nested case-control study in the Spanish primary care database. BIFAP. J Clin Med 8(9):1442. https://doi.org/10.3390/jcm8091442
Gil M, Oliva B, Timoner J et al (2011) Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study. Br J Clin Pharmacol 72(6):965–968. https://doi.org/10.1111/j.1365-2125.2011.04031.x
Gil M, Rodríguez-Miguel A, Montoya-Catalá H et al (2019b) Validation study of colorectal cancer diagnosis in the Spanish primary care database, BIFAP. Pharmacoepidemiol Drug Saf 28(2):209–216. https://doi.org/10.1002/pds.4686
Gorricho J, Garjón J, Alonso A et al (2017) Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study. Br J Clin Pharmacol 83(9):2034–2044. https://doi.org/10.1111/bcp.13288
Hedenmalm K, Blake K, Donegan K et al (2019) A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiol Drug Saf 28(8):1086–1096. https://doi.org/10.1002/pds.4836
Huerta C, Abbing-Karahagopian V, Requena G et al (2016) Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf 25(s1):56–65. https://doi.org/10.1002/pds.3825
Ibáñez L, Sabaté M, Vidal X et al (2019) Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): a cross-national drug utilization study. Br J Clin Pharmacol 85(11):2524–2539. https://doi.org/10.1111/bcp.14071
Lanes S, Brown JS, Haynes K et al (2015) Identifying health outcomes in healthcare databases. Pharmacoepidemiol Drug Saf 24(10):1009–1016. https://doi.org/10.1002/pds.3856
Leon Vazquez F, Bonis J, Bryant Cerezo V et al (2015) Prevencion de fractura osteoporotica en España: uso de farmacos antes y despues de una fractura de cadera. Revista de Osteoporosis y Metabolismo Mineral 7:54–62
Macías Saint-Gerons D, de la Fuente Honrubia C, González Bermejo D et al (2015) Clinical-epidemiological profile of patients initiating intensive statin therapy for the secondary prevention of vascular disease in Spain. Rev Esp Salud Publica 89(2):159–171. https://doi.org/10.4321/S1135-57272015000200005
Macías Saint-Gerons D, de la Fuente Honrubia C, Montero Corominas D et al (2014) Standard and intensive lipid-lowering therapy with statins for the primary prevention of vascular diseases: a population-based study. Eur J Clin Pharmacol 70(1):99–108. https://doi.org/10.1007/s00228-013-1586-5
Macías Saint-Gerons D, Huerta Álvarez C, García Poza P et al (2018) Trazodone utilization among the elderly in Spain. A population based study. Revista De Psiquiatria Y Salud Mental 11(4):208–215. https://doi.org/10.1016/j.rpsm.2016.11.003
Martín-Merino E, de Abajo FJ, Gil M (2015) Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study. Eur J Clin Pharmacol 71(6):759–766. https://doi.org/10.1007/s00228-015-1850-y
Martín-Merino E, Huerta-Álvarez C, Prieto-Alhambra D et al (2017a) Secular trends of use of anti-osteoporotic treatments in Spain: a population-based cohort study including over 1.5 million people and more than 12 years of follow-up. Bone 105:292–298. https://doi.org/10.1016/j.bone.2017.08.031
Martín-Merino E, Huerta-Álvarez C, Prieto-Alhambra D et al (2017b) Cessation rate of anti-osteoporosis treatments and risk factors in Spanish primary care settings: a population-based cohort analysis. Arch Osteoporos 12(1):39. https://doi.org/10.1007/s11657-017-0331-6
Martín-Merino E, Llorente-García A, Corominas DM et al (2019a) The longitudinal incidence of human Papillomavirus vaccination in Spanish primary care in the first 6 years after approval. Pharmaceut Med 33(2):135–144
Martín-Merino E, Llorente-García A, Montero-Corominas D et al (2019b) The recording of human papillomavirus (HPV) vaccination in BIFAP primary care database: a validation study. Pharmacoepidemiol Drug Saf 28(2):201–208. https://doi.org/10.1002/pds.4674
Martín-Merino E, Petersen I, Hawley S et al (2018) Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK. Osteoporos Int 29(2):467–478. https://doi.org/10.1007/s00198-017-4308-5
Martín-Pérez M, Bryant V, Martín-Merino E et al (2019) Are patients adherent to benzodiazepine treatment? Results of a retrospective cohort study in primary care in Spain. Pharmacoepidemiol Drug Saf 28(s2):453. https://doi.org/10.1002/pds.4864
Ministerio de Sanidad Consumo y Bienestar Social (2019) Key indicators. Spanish national health system. http://inclasns.msssi.es/?lang=EN. Accessed 12 Dec 2019
Maciá-Martínez MA, Gil M, Huerta C et al (2020) Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain [published online ahead of print, 2020 Apr 26]. Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.5006
Nadkarni PM, Ohno-Machado L, Chapman WW (2011) Natural language processing: an introduction. J Am Med Inform Assoc 18(5):544–551. https://doi.org/10.1136/amiajnl-2011-000464
OECD/European Union (2018) Health at a Glance: Europe 2018. https://doi.org/10.1787/health_glance_eur-2018-en
Oliva B, Gil M, Montero D et al. (2012) Patterns of topical Calcineurin inhibitor drug use. Impact of regulatory actions in off-label use. Pharmacoepidemiol Drug Saf 21(s3):156. https://doi.org/10.1002/pds
Raman SR, Man KKC, Bahmanyar S et al (2018) Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. The Lancet Psychiatry 5(10):824–835. https://doi.org/10.1016/S2215-0366(18)30293-1
Requena G, Abbing-Karahagopian V, Huerta C et al (2014) Incidence rates and trends of hip/femur fractures in five European countries: comparison using e-healthcare records databases. Calcif Tissue Int 94(6):580–589. https://doi.org/10.1007/s00223-014-9850-y
Requena G, Huerta C, Gardarsdottir H et al (2016a) Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf 25(s1):66–78. https://doi.org/10.1002/pds.3816
Requena G, Logie J, Martin E et al (2016b) Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines. Pharmacoepidemiol Drug Saf 25(s1):79–87. https://doi.org/10.1002/pds.3822
Rivero-Calle I, Pardo-Seco J, Aldaz P et al (2016) Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project). BMC Infect Dis 16(1):645. https://doi.org/10.1186/s12879-016-1974-4
Rodríguez-Martín S, de Abajo FJ, Gil M et al (2019a) Risk of acute myocardial infarction among new users of allopurinol according to serum urate level: a nested case-control study. J Clin Med 8(12):2150. https://doi.org/10.3390/jcm8122150
Rodríguez-Martín S, González-Bermejo D, Rodríguez-Miguel A et al (2019b) Risk of Myocardial infarction among new users of calcium supplements alone or combined with vitamin D: a population-based case-control study. Clin Pharmacol Ther. https://doi.org/10.1002/cpt.1636
Rodríguez-Martín S, Martín-Merino E, Lerma V et al (2018) Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database. Pharmacoepidemiol Drug Saf 27(9):1042–1050. https://doi.org/10.1002/pds.4622
Rodríguez-Miguel A, García-Rodríguez LA, Gil M et al (2019a) Population-based case-control study: chemoprotection of colorectal cancer with non-aspirin nonsteroidal anti-inflammatory drugs and other drugs for pain control. Aliment Pharmacol Ther 50(3):295–305. https://doi.org/10.1111/apt.15333
Rodríguez-Miguel A, García-Rodríguez LA, Gil M et al (2019b) Clopidogrel and low-dose aspirin, alone or together, reduce risk of colorectal cancer. Clin Gastroenterol Hepatol 17(10):2024–2033.e2022. https://doi.org/10.1016/j.cgh.2018.12.012
Rottenkolber M, Voogd E, van Dijk L et al (2015) Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs. Respir Med 109(7):828–837. https://doi.org/10.1016/j.rmed.2015.01.010
Ruigómez A, Brauer R, Rodríguez LAG et al (2014) Ascertainment of acute liver injury in two European primary care databases. Eur J Clin Pharmacol 70(10):1227–1235. https://doi.org/10.1007/s00228-014-1721-y
Sáez-Jiménez R, Bonis J (2015) Estudio descriptivo sobre el uso de antiinflamatorios no esteroideos por vía intramuscular para el tratamiento de la lumbalgia aguda en las consultas de Atención Primaria en España durante 2002–2011. Rev Clin Med Fam [online] 8:103–109
Safeguard Consortium (2015) Final report summary—SAFEGUARD (Safety evaluation of adverse reactions in diabetes). https://cordis.europa.eu/docs/results/282/282521/final1-safeguard_final-publishable-summary-report.pdf. Accessed 12 Dec 2019
Saiz LC, Garjón J, Gorricho J et al (2017) Validation and incidence of community-acquired pneumonia in patients with type 2 diabetes in the BIFAP database. Epidemiol Infect 145(14):3056–3064. https://doi.org/10.1017/S0950268817001868
Saiz LC, Gil M, Alonso A et al (2020) Use of methylphenidate and risk for valvular heart disease: a case-control study nested in the BIFAP cohort. Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.4954
Salvador Rosa A, Moreno Pérez JC, Sonego D et al (2002) The BIFAP project: database for pharmaco-epidemiological research in primary care. Aten Primaria 30(10):655–661. https://doi.org/10.1016/s0212-6567(02)79129-4
Souverein PC, Abbing-Karahagopian V, Martin E et al (2016) Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures. Pharmacoepidemiol Drug Saf 25(s1):88–102. https://doi.org/10.1002/pds.3862
Udo R, Tcherny-Lessenot S, Brauer R et al (2016) The risk of acute liver injury associated with the use of antibiotics–evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project. Pharmacoepidemiol Drug Saf 25(s1):47–55. https://doi.org/10.1002/pds.3841
van den Ham H, Souverein P, Klungel O et al (2019) Risk of major bleeding associated with the use of individual direct oral anticoagulants compared to vitamin K antagonists in patients with non-valvular atrial fibrillation: a meta-analysis of results from multiple population-based cohort studies using a common protocol in Europe and Canada. Pharmacoepidemiol Drug Saf 28(s2):410–411. https://doi.org/10.1002/pds.4864
Weibel D, Dodd C, Mahaux O et al (2019) ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination. Vaccine. https://doi.org/10.1016/j.vaccine.2019.06.040
WHO Collaborating Centre for Drug Statistics Methodology (2019) Guidelines for ATC classification and DDD assignment 2020. Oslo, Norway
WONCA International Classification Committee (1998) ICPC-2. International classification of primary care. 2nd edn. Oxford University Press, Oxford
Acknowledgements
The authors would like to acknowledge the excellent collaboration of the primary care practitioners and pediatricians, and the support of the regional authorities participating in the database (Aragón, Asturias, Canarias, Cantabria, Castilla y León, Castilla-La Mancha, La Rioja, Comunidad de Madrid, Murcia y Navarra). Also, we wish to thank the former members of the BIFAP team for their valuable contribution to the development of the project.
Funding information
The ‘Base de datos para la investigación Farmacoepidemiológica en Atención Primaria’ (BIFAP) is fully financed by the Spanish Agency on Medicines and Medical Devices (AEMPS).
Disclaimer
This document expresses the opinion of the authors of the paper, and may not be understood or quoted as being made on behalf of or reflecting the position of the AEMPS.
Author information
Authors and Affiliations
Consortia
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gil, M. et al. (2021). BIFAP Program: A Data Resource for Pharmacoepidemiological Research in Spain. In: Sturkenboom, M., Schink, T. (eds) Databases for Pharmacoepidemiological Research. Springer Series on Epidemiology and Public Health. Springer, Cham. https://doi.org/10.1007/978-3-030-51455-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-51455-6_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51454-9
Online ISBN: 978-3-030-51455-6
eBook Packages: MedicineMedicine (R0)